UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib

Annals of oncology, 2007-04, Vol.18 (4), p.752-760

2007

Volltextzugriff (PDF)

Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study

Journal of clinical oncology, 2005-10, Vol.23 (28), p.6838-6845

2005

Volltextzugriff (PDF)

Innovative Clinical Trials: The LUNG-MAP Study

Clinical pharmacology and therapeutics, 2015-05, Vol.97 (5), p.488-491

2015

Volltextzugriff (PDF)

Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

Journal of clinical oncology, 2001-07, Vol.19 (13), p.3210-3218

2001

Volltextzugriff (PDF)

Tirapazamine: Prototype for a novel class of therapeutic agents targeting tumor hypoxia

Seminars in oncology, 2002-02, Vol.29 (1), p.102-109

2002

Volltextzugriff (PDF)

Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1728-1733

2001

Volltextzugriff (PDF)

Gefitinib Therapy in Advanced Bronchioloalveolar Carcinoma: Southwest Oncology Group Study S0126

Journal of clinical oncology, 2006-04, Vol.24 (12), p.1807-1813

2006

Volltextzugriff (PDF)

Concurrent Cisplatin, Etoposide, and Chest Radiotherapy in Pathologic Stage IIIB Non–Small-Cell Lung Cancer: A Southwest Oncology Group Phase II Study, SWOG 9019

Journal of clinical oncology, 2002-08, Vol.20 (16), p.3454-3460

2002

Volltextzugriff (PDF)

Twenty-Two Years of Phase III Trials for Patients With Advanced Non–Small-Cell Lung Cancer: Sobering Results

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1734-1742

2001

Volltextzugriff (PDF)

Epidermal growth factor receptor tyrosine kinase inhibitors plus chemotherapy: case closed or is the jury still out?

Journal of clinical oncology, 2005-09, Vol.23 (25), p.5856-5858

2005

Volltextzugriff (PDF)

Time From Treatment to Subsequent Diagnosis of Brain Metastases in Stage III Non–Small-Cell Lung Cancer: A Retrospective Review by the Southwest Oncology Group

Journal of clinical oncology, 2005-05, Vol.23 (13), p.2955-2961

2005

Volltextzugriff (PDF)

Origin and prognostic value of circulating KRAS mutations in lung cancer patients

Cancer letters, 2007-09, Vol.254 (2), p.265-273

2007

Volltextzugriff (PDF)

Phase III Trial of Paclitaxel Plus Carboplatin With or Without Tirapazamine in Advanced Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S0003

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9097-9104

2005

Volltextzugriff (PDF)

Evaluation of Factors Affecting Awareness of and Willingness to Participate in Cancer Clinical Trials

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9282-9289

2005

Volltextzugriff (PDF)

Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2001-04, Vol.93 (8), p.605-618

2001

Volltextzugriff (PDF)

Impact of the Year 2000 Medicare Policy Change on Older Patient Enrollment to Cancer Clinical Trials

Journal of clinical oncology, 2006-01, Vol.24 (1), p.141-144

2006

Volltextzugriff (PDF)

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study

Journal of clinical oncology, 1998-07, Vol.16 (7), p.2459-2465

1998

Volltextzugriff (PDF)

The Cyclin-Dependent Kinase Inhibitor UCN-01 Plus Cisplatin in Advanced Solid Tumors: A California Cancer Consortium Phase I Pharmacokinetic and Molecular Correlative Trial

Clinical cancer research, 2005-06, Vol.11 (12), p.4444-4450

2005

Volltextzugriff (PDF)

Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care

Journal of pain and symptom management, 2004-12, Vol.28 (6), p.548-556

2004

Volltextzugriff (PDF)

Lung-MAP--framework, overview, and design principles

Chinese clinical oncology, 2015-09, Vol.4 (3), p.36

2015

Volltextzugriff (PDF)

Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study

Annals of oncology, 2005-07, Vol.16 (7), p.1076-1080

2005

Volltextzugriff (PDF)

Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicities

Journal of clinical oncology, 1995-02, Vol.13 (2), p.490-496

1995

Volltextzugriff (PDF)

Activity of Docetaxel in Platinum-Treated Non–Small-Cell Lung Cancer: Results of a Phase II Multicenter Trial

Journal of clinical oncology, 2000-01, Vol.18 (1), p.131-135

2000

Volltextzugriff (PDF)

Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: Final results from the california cancer consortium screening and Phase II trial

Cancer, 2004-05, Vol.100 (10), p.2125-2131

2004

Volltextzugriff (PDF)

1 – 25 von 136

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(110)

Publikationsform

Artikel
(134)
Tagungsberichte
(2)

Sprache

Englisch
(135)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(131)
Science & Technology
(131)
Humans
(126)
Oncology
(114)
Biological And Medical Sciences
(82)
Medical Sciences
(82)
Middle Aged
(77)
Male
(76)
Aged
(69)
Female
(68)
Pharmacology. Drug Treatments
(62)
Lung Neoplasms - Drug Therapy
(59)
Adult
(57)
Antineoplastic Agents
(52)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(42)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(39)
Chemotherapy
(37)
Treatment Outcome
(32)
Aged, 80 And Over
(31)
Cisplatin - Administration & Dosage
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib

Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study

Innovative Clinical Trials: The LUNG-MAP Study

Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

Tirapazamine: Prototype for a novel class of therapeutic agents targeting tumor hypoxia

Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment

Gefitinib Therapy in Advanced Bronchioloalveolar Carcinoma: Southwest Oncology Group Study S0126

Concurrent Cisplatin, Etoposide, and Chest Radiotherapy in Pathologic Stage IIIB Non–Small-Cell Lung Cancer: A Southwest Oncology Group Phase II Study, SWOG 9019

Twenty-Two Years of Phase III Trials for Patients With Advanced Non–Small-Cell Lung Cancer: Sobering Results

Epidermal growth factor receptor tyrosine kinase inhibitors plus chemotherapy: case closed or is the jury still out?

Time From Treatment to Subsequent Diagnosis of Brain Metastases in Stage III Non–Small-Cell Lung Cancer: A Retrospective Review by the Southwest Oncology Group

Origin and prognostic value of circulating KRAS mutations in lung cancer patients

Phase III Trial of Paclitaxel Plus Carboplatin With or Without Tirapazamine in Advanced Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S0003

Evaluation of Factors Affecting Awareness of and Willingness to Participate in Cancer Clinical Trials

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer

Impact of the Year 2000 Medicare Policy Change on Older Patient Enrollment to Cancer Clinical Trials

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study

The Cyclin-Dependent Kinase Inhibitor UCN-01 Plus Cisplatin in Advanced Solid Tumors: A California Cancer Consortium Phase I Pharmacokinetic and Molecular Correlative Trial

Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care

Lung-MAP--framework, overview, and design principles

Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study

Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicities

Activity of Docetaxel in Platinum-Treated Non–Small-Cell Lung Cancer: Results of a Phase II Multicenter Trial

Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: Final results from the california cancer consortium screening and Phase II trial

Suchergebnisse filtern